equitybuy

TXN

Trust-weighted public proof page for TXN. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity
145 / 100
Current score
2.49
Thesis calls
6
Active decisions
6

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

Paper proposes a fully automated resonant core-loss measurement setup for sub‑MHz magnetics using digitally controlled switched-capacitor sequences plus onboard signal processing, replacing manual tuning + heavy FFT workflows. If commercialized, it reduces magnetics characterization time (1000+ points/20s) and labor, potentially accelerating development cycles for high‑frequency power magnetics used in EV/inverter, data-center/AI power, and industrial supplies. Near-term investability hinges on

Mentioned: Jun 1, 2026, 12:00 AM EDTConviction: 31 / 100
Source: Resonant Method-based Fully Automated Core Loss Measurement System for Sub-MHz Magnetics With Switched Capacitor Sequence

Post reports Texas Instruments (TXN) Q2 revenue $5.5B, strength in automotive and data center, Q3 revenue target up to $6.15B on “broad-based demand recovery,” and trailing FCF $6.5B. Actionable mainly as an earnings/guidance + cycle-recovery signal for TXN; limited broader sector read-through due to lack of peer detail.

Mentioned: Jul 23, 2026, 11:52 AM EDTConviction: 58 / 100
Source: Seeking Alpha @SeekingAlpha 47m Texas Instruments $TXN posted Q2 revenue of $5.5B, driven by strength in automotive a...

Post summarizes Texas Instruments (TXN) 2Q26 results and 3Q26 guide, highlighting above-seasonal revenue growth, margin expansion, and a favorable inventory/capacity position that could enable share gains as growth broadens from industrial/data center into automotive.

Mentioned: Jul 23, 2026, 4:39 AM EDTConviction: 64 / 100
Source: Sravan Kundojjala @SKundojjala 23h Texas Instruments 2Q26 - Revenue up +13% q/q, +23% y/y to $5.46B at 61.4% GM (+340...

Markets were range-bound ahead of major Big Tech earnings, with late-session/after-hours reactions to Texas Instruments, Alphabet, Tesla, and IBM. Discussion also flagged an FDA food safety alert pressuring restaurant stocks, positioning in options markets into earnings, Samsung’s foldable-phone launch as a competitive datapoint ahead of Apple, and ongoing themes around AI infrastructure spend vs margin pressure. Mentions of Wells Fargo’s post–asset-cap growth outlook and a Blackstone/alt-manage

Mentioned: Jul 22, 2026, 6:11 PM EDTConviction: 53 / 100
Source: Stocks Churn Before Big-Tech Earnings | The Close 7/22/2026

The source is essentially a Bloomberg program description mentioning that earnings reports are/will be discussed for Alphabet, Tesla, IBM, and Texas Instruments. It contains no actual earnings figures, guidance, surprises, or market reaction details, so it offers minimal actionable trading information beyond identifying near-term earnings/event risk for the named tickers.

Mentioned: Jul 22, 2026, 4:24 PM EDTConviction: 21 / 100
Source: Alphabet, Tesla, IBM, Texas Instruments Earnings Reports | Closing Bell
citrinixopen

Post cites a customer letter (Chinese) stating analog semiconductor supply is tight due to broad demand increases, impacting Analog Devices (ADI) with lead times extended up to six months. This is a supply/demand tightness datapoint for analog semis; actionable mainly as a sector/stock sentiment and margin/pricing-power signal, but lacks specific financial impact, timing, or trade levels.

Mentioned: Jul 4, 2026, 1:47 AM EDTConviction: 50 / 100
Source: Jukan @ ICML @jukan05 3h Analog semiconductor lead times are now up to six months!! 駿HaYaO @QQ_Timmy 3h Analog Device...

Current stance

Recommendationbuy
Authors5
Active decisions6
Latest pricen/a

Investment decisions

TXN
research_buy

TXN
research_buy

TXN
research_buy

TXN
risk_review

TXN
research_buy

TXN
research_buy

TXN
watch

Unlock full asset monitoring

Create an account to inspect complete asset history, trust-weighted rankings, and persisted evidence across authors, theses, and market events.